US91307C1027 - Common Stock
UNITED THERAPEUTICS CORP
NASDAQ:UTHR (12/20/2024, 8:00:01 PM)
After market: 359.58 0 (0%)359.58
-0.58 (-0.16%)
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. The company is headquartered in Silver Spring, Maryland and currently employs 1,168 full-time employees. The company markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended-Release Tablets (Orenitram); and Adcirca (tadalafil) Tablets (Adcirca). Tyvaso DPI and nebulized Tyvaso are also approved to treat pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also markets and sells an oncology product, Unituxin (dinutuximab) Injection (Unituxin) for treatment of high-risk neuroblastoma, and the Remunity Pump for Remodulin (Remunity). Tyvaso DPI is a drug-device combination product that incorporates the dry powder formulation technology and Dreamboat inhalation device technology used in MannKind’s Afrezza (insulin human) Inhalation Powder.
UNITED THERAPEUTICS CORP
1000 Spring St
Silver Spring MARYLAND 20910
P: 13016089292
CEO: Martine A. Rothblatt
Employees: 1168
Website: https://www.unither.com/
Electric aerospace startup Beta Technologies Inc. raised $318 million from investors to fund the production of aircraft that can takeoff and land vertically.
Here you can normally see the latest stock twits on UTHR, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: